Summary of Purpose
Intravenous thrombolysis with recombinant tissue-type plasminogen activator (IV t-PA) has been the only proven therapy for acute ischemic stroke (AIS) for almost 20 years. Whether IV t-PA prior to endovascular clot retrieval is beneficial for AIS patients with a proximal vessel occlusion in the anterior circulation has currently become a matter of debate and is a relevant unanswered question in clinical practice....Read More →
The following dates are available for this trial. Trial information last updated on 16 February 2018.
|29 Nov 2017||12 Jun 2017||31 Dec 2020||31 Dec 2021||1 Feb 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Stent-retriever thrombectomy with revascularization device of the Solitaire™ type
- Intravenous thrombolysis with recombinant tissue-type plasminogen activator (IV t-PA)